Rabbit Recombinant Monoclonal SOX11 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 13 publications.
View Alternative Names
Transcription factor SOX-11, SOX11
- IP
Lab
Immunoprecipitation - Anti-SOX11 antibody [EPR8192] (AB134107)
SOX11 was immunoprecipitated from 0.35 mg Y79 (Human retinoblastoma retinoblastoma) whole cell lysate 10 μg with 134107 at 1/40 dilution (2μg). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : Y79 (Human retinoblastoma retinoblastoma) whole cell lysate 10 μg
Lane 2 : ab134107 IP in Y79 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab134107 in Y79 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-SOX11 antibody [EPR8192] (ab134107)
Predicted band size: 47 kDa
Observed band size: 60 kDa
false
- WB
Unknown
Western blot - Anti-SOX11 antibody [EPR8192] (AB134107)
All lanes:
Western blot - Anti-SOX11 antibody [EPR8192] (ab134107) at 1/1000 dilution
Lane 1:
Human fetal brain lysate at 10 µg
Lane 2:
Y-79 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 47 kDa
Observed band size: 60 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-SOX11 antibody [EPR8192] (AB134107)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-SOX11 antibody [EPR8192] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2410808 PubMed39555675
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature cell biology 26:2020-2034 PubMed39528700
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:2120 PubMed38459012
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:7335 PubMed36443325
2022
Applications
Unspecified application
Species
Unspecified reactive species
Development (Cambridge, England) 148: PubMed34184026
2021
Applications
Unspecified application
Species
Unspecified reactive species
Disease models & mechanisms 14: PubMed33969421
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 44:1511-1523 PubMed32945462
2020
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 19:619 PubMed31234811
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 25:2689-2703.e3 PubMed30517858
2018
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 8:16196 PubMed30385877
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com